Sign In
Buy FC
$21.45
-0.0700 (-0.325%)
At Close: Jul 31, 2026
Franklin Covey Reports Third Quarter Fiscal 2026 Financial Results
04:15pm, Wednesday, 01'st Jul 2026
SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner that gives strategy the human edge, announced today its financial results for
The AI Winners Won't Just Be The Most Technological. They'll Be The Most Human.
09:08am, Wednesday, 01'st Jul 2026
SALT LAKE CITY--(BUSINESS WIRE)-- #AI--The AI Winners Won't Just Be The Most Technological. They'll Be The Most Human.
Franklin Covey Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
02:35am, Thursday, 25'th Jun 2026
Franklin Covey Co. (NYSE:FC) will release its third quarter earnings report after the closing bell on Wednesday, July 1.
Franklin Covey to Report Third Quarter Fiscal 2026 Results
04:30pm, Wednesday, 17'th Jun 2026
SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner that gives strategy the human edge, announced today that the conference call
Firm Capital Mortgage Investment Corporation Announces Election of Directors
05:01pm, Tuesday, 16'th Jun 2026
/NOT FOR DISTRIBUTION OVER U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Firm Capital Mortgage Investment Corporation (the “Corporation�
[url="]FranklinCovey[/url] ([url="]NYSE: FC[/url]), a global leader in organizational performance improvement, today announced it will host James Patterson, Liz
SALT LAKE CITY--(BUSINESS WIRE)-- #Change--FranklinCovey will Host James Patterson, Liz Wiseman, Patrick Leddin and Jennifer Colosimo on Two Webinars for HR and L&D Leaders on June 26 and 30.
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
10:01am, Wednesday, 27'th May 2026
[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living wi
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
10:00am, Wednesday, 27'th May 2026
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living with gastrointestinal (GI) and
80% of Individual Contributors Say Their Manager's Approach to AI is Hands-Off, FranklinCovey Research Finds
01:00pm, Thursday, 21'st May 2026
As organizations race to capture the benefits of artificial intelligence, research from [url="]FranklinCovey[/url] Institute reveals a critical obstacle: most
80% of Individual Contributors Say Their Manager's Approach to AI is Hands-Off, FranklinCovey Research Finds
12:38pm, Thursday, 21'st May 2026
SALT LAKE CITY--(BUSINESS WIRE)-- #AI--As organizations race to capture the benefits of artificial intelligence, research from FranklinCovey Institute reveals a critical obstacle: most employees feel
Diploma H1 Earnings Call Highlights
05:07am, Tuesday, 19'th May 2026
Diploma LON: DPLM reported what management described as a “very strong” first half for the six months ended March 31, 2026, with double-digit organic growth, higher margins and upgraded full-year
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
03:00pm, Sunday, 17'th May 2026
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that full results of its ADVANCE OUTCOMES study are being present
TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB. K, FC.DB. L and FC.DB.M) today released its financial statements for the
Franklin Covey Q2 Earnings Call Highlights
03:07am, Friday, 03'rd Apr 2026
Franklin Covey (NYSE: FC) executives said the company's fiscal second quarter 2026 results showed continued momentum from its go-to-market changes in Enterprise North America, with invoiced amounts ri
